Phase 2 MASH - Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials

4 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–4 of 4 trials

Recruiting

Phase 2

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Madrigal Pharmaceuticals, Inc.120 enrolled15 locationsNCT07335601

Recruiting

Phase 1Phase 2

Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Healthy ParticipantsMASH - Metabolic Dysfunction-Associated Steatohepatitis

Tangram Therapeutics Plc99 enrolled1 locationNCT07427680

Recruiting

Phase 2

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Rivus Pharmaceuticals, Inc.180 enrolled33 locationsNCT07491458

Recruiting

Phase 2

Digoxin In NASH (CODIN)

MASH - Metabolic Dysfunction-Associated SteatohepatitisNAFLDNASH

Yale University144 enrolled2 locationsNCT06588699